EMBL-EBI | Chemical Biology | ChEBI

Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search

CHEBI:133013 - brivaracetam

ChEBI IDCHEBI:133013
ChEBI Namebrivaracetam
Stars
DefinitionA non-proteinogenic amino acid derivative that is butanamide in which the pro-S hydrogen at position 2 is replaced by a (4R)-2-oxo-4-propylpyrrolidin-1-yl. Used for treatment of partial onset seizures related to epilepsy.
Last Modified22 February 2017
SubmitterSteve
DownloadsMolfile
FormulaC11H20N2O2
Net Charge0
Average Mass212.293
Monoisotopic Mass212.15248
SMILESCCC[C@@H]1CC(=O)N([C@@H](CC)C(N)=O)C1
InChIInChI=1S/C11H20N2O2/c1-3-5-8-6-10(14)13(7-8)9(4-2)11(12)15/h8-9H,3-7H2,1-2H3,(H2,12,15)/t8-,9+/m1/s1
InChIKeyMSYKRHVOOPPJKU-BDAKNGLRSA-N
Wikipedia
Roles Classification
Application:
anticonvulsant  A drug used to prevent seizures or reduce their severity.
ChEBI Ontology
Outgoing Relation(s)
brivaracetam (CHEBI:133013) has functional parent L-α-aminobutyric acid (CHEBI:35619)
brivaracetam (CHEBI:133013) has role anticonvulsant (CHEBI:35623)
brivaracetam (CHEBI:133013) is a non-proteinogenic amino acid derivative (CHEBI:83812)
brivaracetam (CHEBI:133013) is a γ-lactam (CHEBI:74222)
IUPAC Name 
(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide
INN  Source
brivaracetamKEGG DRUG
Synonyms  Source
2-(2-Oxo-4-propylpyrrolidin-1-yl)butanamideChemIDplus
UCB 34714ChemIDplus
UCB34714ChemIDplus
Brand Name  Source
BriviactChemIDplus
Manual XrefsDatabases
D08879KEGG DRUG
BrivaracetamWikipedia
5068DrugCentral
Registry NumbersSources
Reaxys:9629290Reaxys
CAS:357336-20-0KEGG DRUG
CAS:357336-20-0ChemIDplus
Citations